Can-Fite BioPharma Ltd. (CANF)

AMEX: CANF · Real-Time Price · USD

1.07

0.03 (2.88%)

At close: May 02, 2025, 12:48 PM

Can-Fite BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	4.83M	4.28M	2.98M	4.39M	8.27M	2.7M	3.62M	3.5M	8.11M
Short-Term Investments	3.06M	4.64M	5M	14.75M	75K	64K	273K	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	912K	n/a	914.66K	9.61K
Other Long-Term Assets	n/a	n/a	-126K	-185K	-123K	n/a	2K	5.18K	5.24
Receivables	n/a	n/a	47K	48K	18K	n/a	n/a	66K	21.84K
Inventory	n/a	n/a	-39K	-48K	964K	n/a	-3.97M	-3.3M	n/a
Other Current Assets	1.02M	78K	n/a	n/a	n/a	651K	41K	66K	n/a
Total Current Assets	8.98M	9.91M	9.16M	20.07M	9.4M	7.14M	7.9M	6.87M	10.1M
Property-Plant & Equipment	138K	81K	126K	185K	123K	118K	47K	46.03K	53.29K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	138K	81K	126K	185K	123K	1.03M	49K	965.88K	62.91K
Total Assets	9.12M	9.99M	9.28M	20.25M	9.52M	8.17M	7.95M	7.83M	10.17M
Account Payables	618K	427K	896K	954K	561K	2.16M	1.07M	427K	1.25M
Deferred Revenue	405K	622K	783K	818K	334K	469K	926K	373.75K	321.58K
Short-Term Debt	n/a	n/a	48K	53K	43K	36K	n/a	n/a	n/a
Other Current Liabilities	675K	250K	444K	550K	192K	409K	973K	330K	829.5K
Total Current Liabilities	2.05M	2.02M	2.5M	2.73M	1.27M	3.27M	3.12M	1.8M	2.5M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	846K	2.62M
Total Long-Term Liabilities	1.63M	1.73M	2.31M	3.14M	2.18M	2.46M	1.82M	2.98M	3.79M
Total Liabilities	3.68M	3.75M	4.81M	5.87M	3.45M	5.73M	4.94M	4.78M	6.29M
Total Debt	104K	40K	62K	124K	67K	75K	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	60.65M	33.04M	8.22M	2.63M	2.39M	1.83M
Retained Earnings	-166.36M	-158.48M	-150.85M	-140.67M	-125.47M	-110.31M	-100.62M	-105.66M	-90.98M
Comprehensive Income	1.13M	1.13M	1.13M	1.13M	1.13M	1.13M	6.93M	6.28M	5.08M
Shareholders Equity	5.44M	6.24M	4.47M	14.38M	6.07M	2.44M	3.02M	3.05M	3.87M
Total Investments	3.06M	4.64M	5M	14.75M	75K	64K	273K	914.66K	9.61K